Skip to main content

Investor

By Dave Muoio | 12:47 pm | February 04, 2020
Paris, France-based Inato incorporates a slew of logistical data points to help biopharma clients avoid underperforming study sites.
By Dave Muoio | 09:00 am | February 04, 2020
The chronic MSK health platform has doubled its customer base within the last six months, CEO and cofounder Daniel Perez says.
By Tammy Lovell | 04:54 am | February 04, 2020
Product offering will be expanded to help doctors in the UK and Germany deliver preventative care.
By Dave Muoio | 03:44 pm | February 03, 2020
Legacy provides customers with a personalized digital report of their reproductive health within 24 hours of receiving a sample.
By Dave Muoio | 02:31 pm | January 31, 2020
While the tech-enabled primary care provider set the initial pricing of its shares at $14 apiece, prices are climbing in the early hours of its IPO.
By Tammy Lovell | 01:29 pm | January 31, 2020
Report predicts growth will be driven by provider operations and alternative care companies.
By Dave Muoio | 03:47 pm | January 30, 2020
The company's tech platform enables same-day prescription deliveries.
By Dave Muoio | 05:21 pm | January 28, 2020
The Silicon Valley EHR vendor received “sponsorship” payments from unnamed pharmaceutical companies so that the latter’s marketing team could influence the design of CDS features, according to the Department of Justice.
By MobiHealthNews | 03:27 pm | January 28, 2020
The MobiHealthNews staff shares its thoughts on how HIPAA, investor funding, digital health commercialization and other focus areas will be changing over the course of the new year.
By Dave Muoio | 12:37 pm | January 28, 2020
Formerly known as Enzyme Health, the company's strategy is comprised of two major avenues: telehealth staffing opportunities for practitioners, and a scalable telehealth platform for companies.